Q3 2024 |
189 |
$307M |
+$5.16M |
-$41M |
-$35.9M |
TPL, AAPL, META, MGK, NVDA
|
13F-HR |
10/29/2024, 02:10 PM |
Q2 2024 |
198 |
$322M |
+$20.8M |
-$33.3M |
-$12.5M |
TPL, IVV, AAPL, MGK, META
|
13F-HR |
7/31/2024, 10:39 AM |
Q1 2024 |
715 |
$341M |
+$47.7M |
-$27.4M |
+$20.3M |
TPL, IVV, AAPL, META, MGK
|
13F-HR |
5/13/2024, 12:19 PM |
Q4 2023 |
194 |
$301M |
+$8.32M |
-$9.45M |
-$1.13M |
AAPL, TPL, IVV, BBIO, MDB
|
13F-HR |
2/5/2024, 03:17 PM |
Q3 2023 |
190 |
$276M |
+$5.07M |
-$6.32M |
-$1.25M |
TPL, AAPL, IVV, MDB, MGK
|
13F-HR |
11/8/2023, 11:48 AM |
Q2 2023 |
191 |
$280M |
+$14.5M |
-$6.07M |
+$8.46M |
AAPL, TPL, IVV, MDB, MGK
|
13F-HR |
8/9/2023, 12:14 PM |
Q1 2023 |
184 |
$261M |
+$10.3M |
-$6.52M |
+$3.81M |
TPL, AAPL, IVV, PLRX, MGK
|
13F-HR |
5/1/2023, 01:50 PM |
Q4 2022 |
182 |
$242M |
+$7.74M |
-$17.1M |
-$9.31M |
TPL, IVV, AAPL, PLRX, MGK
|
13F-HR |
2/7/2023, 09:58 AM |
Q3 2022 |
185 |
$237M |
+$12M |
-$4.81M |
+$7.17M |
TPL, GBT, AAPL, IVV, MGK
|
13F-HR |
11/9/2022, 11:15 AM |
Q2 2022 |
183 |
$232M |
+$6.59M |
-$8.95M |
-$2.36M |
TPL, AAPL, IVV, GBT, MGK
|
13F-HR |
8/11/2022, 01:06 PM |
Q1 2022 |
200 |
$283M |
+$3.76M |
-$7.97M |
-$4.21M |
AAPL, TPL, MDB, IVV, MGK
|
13F-HR |
5/3/2022, 12:26 PM |
Q4 2021 |
211 |
$306M |
+$12.9M |
-$9.13M |
+$3.77M |
MDB, AAPL, IVV, TPL, MGK
|
13F-HR |
2/9/2022, 12:07 PM |
Q3 2021 |
198 |
$291M |
+$8.3M |
-$5.66M |
+$2.64M |
MDB, TPL, IVV, AAPL, MGK
|
13F-HR |
10/28/2021, 04:05 PM |
Q2 2021 |
199 |
$302M |
+$15.3M |
-$4.02M |
+$11.3M |
TPL, BBIO, IVV, AAPL, MDB
|
13F-HR |
8/5/2021, 01:46 PM |
Q1 2021 |
190 |
$272M |
+$16.4M |
-$8.84M |
+$7.56M |
TPL, BBIO, GBT, IVV, AAPL
|
13F-HR |
5/6/2021, 01:23 PM |
Q4 2020 |
183 |
$254M |
+$28.1M |
-$13.1M |
+$15M |
BBIO, GBT, AAPL, MDB, IVV
|
13F-HR |
2/16/2021, 11:26 AM |
Q3 2020 |
163 |
$212M |
+$19.3M |
-$17.5M |
+$1.82M |
GBT, AAPL, RLAY, IVV, AMZN
|
13F-HR |
11/3/2020, 12:29 PM |
Q2 2020 |
166 |
$202M |
+$20.9M |
-$12.3M |
+$8.6M |
GBT, MDB, IVV, AMZN, META
|
13F-HR |
8/6/2020, 01:31 PM |
Q1 2020 |
145 |
$156M |
+$8.74M |
-$13.7M |
-$4.95M |
GBT, IVV, META, AMZN, MDB
|
13F-HR |
4/30/2020, 10:31 AM |
Q4 2019 |
159 |
$209M |
+$10.4M |
-$31.5M |
-$21.1M |
GBT, PTLA, IVV, MYOK, META
|
13F-HR |
2/10/2020, 01:26 PM |
Q3 2019 |
180 |
$202M |
+$28.3M |
-$5.19M |
+$23.1M |
GBT, PTLA, IVV, MYOK, META
|
13F-HR |
11/14/2019, 01:43 PM |
Q2 2019 |
152 |
$183M |
+$7.57M |
-$10.6M |
-$3.02M |
GBT, PTLA, MYOK, IVV, META
|
13F-HR |
8/1/2019, 02:29 PM |
Q1 2019 |
155 |
$187M |
+$11.5M |
-$6.06M |
+$5.4M |
GBT, PTLA, MYOK, IVV, MO
|
13F-HR |
5/6/2019, 01:37 PM |
Q4 2018 |
145 |
$155M |
+$11.2M |
-$17.5M |
-$6.22M |
GBT, MYOK, PTLA, IVV, MO
|
13F-HR |
2/12/2019, 01:26 PM |
Q3 2018 |
166 |
$189M |
+$9.64M |
-$10.8M |
-$1.14M |
GBT, MYOK, PTLA, IVV, MO
|
13F-HR |
11/13/2018, 02:49 PM |
Q2 2018 |
157 |
$185M |
+$11M |
-$11M |
+$29.1K |
GBT, MYOK, PTLA, IVV, META
|
13F-HR |
8/14/2018, 12:17 PM |
Q1 2018 |
145 |
$179M |
+$7.33M |
-$13.4M |
-$6.02M |
GBT, MYOK, PTLA, IVV, MO
|
13F-HR |
5/3/2018, 11:35 AM |
Q4 2017 |
149 |
$187M |
+$28M |
-$8.31M |
+$19.7M |
GBT, MYOK, PTLA, IVV, MO
|
13F-HR |
2/5/2018, 01:54 PM |
Q3 2017 |
138 |
$160M |
+$22M |
-$5.55M |
+$16.5M |
GBT, PTLA, MYOK, MO, GILD
|
13F-HR |
11/9/2017, 02:03 PM |
Q2 2017 |
138 |
$138M |
+$13.9M |
-$5.99M |
+$7.93M |
PTLA, GBT, MO, CVS, META
|
13F-HR |
8/3/2017, 12:55 PM |
Q1 2017 |
135 |
$126M |
+$13.7M |
-$2.68M |
+$11M |
GBT, PTLA, MO, CVS, IYK
|
13F-HR |
5/9/2017, 02:48 PM |
Q4 2016 |
124 |
$104M |
+$8.68M |
-$8.88M |
-$200K |
PTLA, MO, CVS, GILD, IYK
|
13F-HR |
2/14/2017, 11:54 AM |
Q3 2016 |
124 |
$109M |
+$7.58M |
-$4.08M |
+$3.51M |
PTLA, CVS, GILD, MO, IYK
|
13F-HR |
11/10/2016, 01:49 PM |
Q2 2016 |
122 |
$102M |
+$4.69M |
-$3.46M |
+$1.23M |
PTLA, CVS, MO, GILD, IYK
|
13F-HR |
8/4/2016, 01:00 PM |
Q1 2016 |
121 |
$98.7M |
+$5.5M |
-$17.7M |
-$12.2M |
CVS, GILD, PTLA, MO, IYK
|
13F-HR |
5/10/2016, 12:11 PM |
Q4 2015 |
126 |
$117M |
+$7.49M |
-$7.89M |
-$402K |
PTLA, GILD, CVS, MO, BIIB
|
13F-HR |
2/9/2016, 10:22 AM |
Q3 2015 |
117 |
$114M |
+$6.42M |
-$4.33M |
+$2.09M |
PTLA, GILD, CVS, MO, IYK
|
13F-HR |
11/12/2015, 01:37 PM |
Q2 2015 |
116 |
$127M |
+$6.8M |
-$2.89M |
+$3.91M |
PTLA, GILD, CVS, BIIB, IYK
|
13F-HR |
8/13/2015, 09:58 AM |
Q1 2015 |
113 |
$122M |
+$8.26M |
-$7.38M |
+$876K |
PTLA, GILD, CVS, BIIB, MO
|
13F-HR |
4/30/2015, 12:28 PM |
Q4 2014 |
109 |
$118M |
+$13M |
-$11.1M |
+$1.87M |
PTLA, GILD, CVS, BIIB, MO
|
Restatement |
2/10/2015, 10:33 AM |
Q3 2014 |
109 |
$116M |
+$3.91M |
-$7.08M |
-$3.18M |
PTLA, GILD, CVS, IYK, GLNG
|
13F-HR |
11/6/2014, 12:17 PM |
Q2 2014 |
113 |
$121M |
+$13.4M |
-$6.9M |
+$6.46M |
PTLA, GILD, CVS, GLNG, IYK
|
13F-HR |
7/31/2014, 08:34 AM |
Q1 2014 |
110 |
$108M |
+$3.63M |
-$48.3M |
-$44.7M |
CVS, GILD, IYK, BIIB, PTLA
|
13F-HR |
4/23/2014, 09:03 AM |
Q4 2013 |
141 |
$151M |
$0 |
$0 |
|
PTLA, GILD, SAFT, CVS, BIIB
|
13F-HR |
2/6/2014, 11:51 AM |